Skip to content
10-Q

Quarterly Report

ABEONA THERAPEUTICS INC. ABEO

0001641172-25-010516

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 51.16M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $11.14M
Long Term Debt Q1 2025 · Dec 31, 2024 $13.04M
Short Term Investments Q1 2025 · Mar 31, 2025 $68.22M
Short Term Investments Q1 2025 · Dec 31, 2024 $74.36M
Current Liabilities Q1 2025 · Mar 31, 2025 $17.98M
Current Liabilities Q1 2025 · Dec 31, 2024 $16.59M
Total Liabilities Q1 2025 · Mar 31, 2025 $57.97M
Total Liabilities Q1 2025 · Dec 31, 2024 $64.9M
Current Assets Q1 2025 · Mar 31, 2025 $88.12M
Current Assets Q1 2025 · Dec 31, 2024 $100.85M
Total Assets Q1 2025 · Mar 31, 2025 $99.36M
Total Assets Q1 2025 · Dec 31, 2024 $108.93M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $23.36M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $17.56M
Shares Diluted Q1 2025 · Mar 31, 2024 27.32M sh
Capex Q1 2025 · Mar 31, 2024 $725K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$14.54M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$8.88M
Stockholders Equity Q1 2025 · Dec 31, 2023 $14.83M
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.16
Eps Basic Q1 2025 · Mar 31, 2024 −$1.16
Rd Expense Q1 2025 · Mar 31, 2024 $7.21M
Net Income Q1 2025 · Mar 31, 2024 −$31.58M
Operating Income Q1 2025 · Mar 31, 2024 −$14.33M